- iTransfuse Online Learning
- About us
- Contact us
- Site map
As a joint initiative of the National Health and Medical Research Council (NHMRC), Australasian Society of Blood Transfusion (ASBT) and other relevant groups, the NHMRC/ASBT Clinical Practice Guidelines for the Use of Blood Components(1) were developed to support clinical decisions about appropriate transfusion practices and the use of blood components (red blood cells, platelets, fresh frozen plasma and cryoprecipitate).
A review of these guidelines is currently being undertaken with funding and project management provided by the National Blood Authority (NBA) on behalf of all governments.
The NBA facilitated the formulation of a Steering Committee, Expert Working Group and Clinical/Consumer Reference Groups to develop a comprehensive, evidence-based Patient Blood Management Guideline comprising six modules as follows:
Module 1 – Critical Bleeding/Massive Transfusion (released 31 March 2011)
Module 2 – Peri-operative (released 9 March 2012)
Module 3 – Medical (released 12 September 2012)
Module 4 – Intensive Care (in development)
Module 5 – Obstetric (expected to commence in 2012)
Module 6 – Paediatric / Neonates (expected to commence in 2012)
Revision of the 2001 guidelines was needed due to:(2)
The development of the evidence-based clinical patient blood management guidelines has involved developing a set of clinical research questions and systematically reviewing the scientific literature for evidence related to those questions, then developing and grading recommendations based on a structured assessment of the evidence.(3)